Seguir
Audrey GABELLE
Audrey GABELLE
Maître de Conférence des Universités Praticien Hospitalier de Neurologie, Université de Montpellier
Dirección de correo verificada de chu-montpellier.fr
Título
Citado por
Citado por
Año
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease
S Salloway, R Sperling, NC Fox, K Blennow, W Klunk, M Raskind, ...
New England Journal of Medicine 370 (4), 322-333, 2014
17872014
Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease
RS Doody, RG Thomas, M Farlow, T Iwatsubo, B Vellas, S Joffe, ...
New England Journal of Medicine 370 (4), 311-321, 2014
15372014
Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints …
S Andrieu, S Guyonnet, N Coley, C Cantet, M Bonnefoy, S Bordes, ...
The Lancet Neurology 16 (5), 377-389, 2017
5802017
A meta-analysis of human embryonic stem cells transcriptome integrated into a web-based expression atlas
S Assou, T Le Carrour, S Tondeur, S Ström, A Gabelle, S Marty, L Nadal, ...
Stem cells 25 (4), 961-973, 2007
3972007
APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases
HM Lanoiselée, G Nicolas, D Wallon, A Rovelet-Lecrux, M Lacour, ...
PLoS medicine 14 (3), e1002270, 2017
3372017
MAPT study: a multidomain approach for preventing Alzheimer’s disease: design and baseline data
B Vellas, I Carrie, S Gillette-Guyonnet, J Touchon, T Dantoine, ...
The journal of prevention of Alzheimer's disease 1 (1), 13, 2014
2512014
A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer’s disease
NR Barthélemy, Y Li, N Joseph-Mathurin, BA Gordon, J Hassenstab, ...
Nature medicine 26 (3), 398-407, 2020
2492020
High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early-onset Alzheimer disease
C Pottier, D Hannequin, S Coutant, A Rovelet-Lecrux, D Wallon, ...
Molecular psychiatry 17 (9), 875-879, 2012
2482012
Demographic, neurological and behavioural characteristics and brain perfusion SPECT in frontal variant of frontotemporal dementia
IL Ber, E Guedj, A Gabelle, P Verpillat, M Volteau, C Thomas-Anterion, ...
Brain 129 (11), 3051-3065, 2006
1982006
Cerebrospinal fluid amyloid β40 is decreased in cerebral amyloid angiopathy
MM Verbeek, BPH Kremer, MO Rikkert, PHMF Van Domburg, ME Skehan, ...
Annals of Neurology: Official Journal of the American Neurological …, 2009
1942009
SQSTM1 mutations in French patients with frontotemporal dementia or frontotemporal dementia with amyotrophic lateral sclerosis
I Le Ber, A Camuzat, R Guerreiro, K Bouya-Ahmed, J Bras, G Nicolas, ...
JAMA neurology 70 (11), 1403-1410, 2013
1692013
C9orf72 repeat expansions are a rare genetic cause of parkinsonism
S Lesage, I Le Ber, C Condroyer, E Broussolle, A Gabelle, S Thobois, ...
Brain 136 (2), 385-391, 2013
1642013
TREM2 R47H variant as a risk factor for early-onset Alzheimer's disease
C Pottier, D Wallon, S Rousseau, A Rovelet-Lecrux, AC Richard, ...
Journal of Alzheimer's Disease 35 (1), 45-49, 2013
1642013
Memantine in behavioral variant frontotemporal dementia: negative results
M Vercelletto, C Boutoleau-Bretonnière, C Volteau, M Puel, S Auriacombe, ...
Journal of Alzheimer's disease 23 (4), 749-759, 2011
1412011
Commentary on “A roadmap for the prevention of dementia II. Leon Thal Symposium 2008.” The Multidomain Alzheimer Preventive Trial (MAPT): a new approach to the prevention of …
S Gillette-Guyonnet, S Andrieu, T Dantoine, JF Dartigues, J Touchon, ...
Alzheimer's & Dementia 5 (2), 114-121, 2009
1222009
Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer’s disease and PET amyloid-positive patient identification
NR Barthélemy, RJ Bateman, C Hirtz, P Marin, F Becher, C Sato, ...
Alzheimer's research & therapy 12 (1), 1-11, 2020
1152020
The French series of autosomal dominant early onset Alzheimer's disease cases: mutation spectrum and cerebrospinal fluid biomarkers
D Wallon, S Rousseau, A Rovelet-Lecrux, M Quillard-Muraine, ...
Journal of Alzheimer's Disease 30 (4), 847-856, 2012
1122012
Risk of Alzheimer's disease biological misdiagnosis linked to cerebrospinal collection tubes
A Perret-Liaudet, M Pelpel, Y Tholance, B Dumont, H Vanderstichele, ...
Journal of Alzheimer's Disease 31 (1), 13-20, 2012
1102012
Differential mass spectrometry profiles of tau protein in the cerebrospinal fluid of patients with Alzheimer’s disease, progressive supranuclear palsy, and dementia with lewy …
NR Barthélemy, A Gabelle, C Hirtz, F Fenaille, N Sergeant, ...
Journal of Alzheimer's Disease 51 (4), 1033-1043, 2016
1082016
Plasma amyloid levels within the Alzheimer's process and correlations with central biomarkers
O Hanon, JS Vidal, S Lehmann, S Bombois, B Allinquant, JM Tréluyer, ...
Alzheimer's & Dementia 14 (7), 858-868, 2018
1052018
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20